Insulin biosimilar (Sedico) |
|
Approved |
Sedico |
Insulin H bio R |
Egypt |
Diabetes Mellitus |
Sedico |
2013-02-01 |
Diabetes Mellitus |
Details
|
Oral insulin (Generex Biotechnology) |
|
Approved |
Generex Biotechnology Corp |
Oralin, Oralgen, Oral-lyn, Recosulin |
Ecuador |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
null |
2005-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insul 30/70 biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insul 30-70 |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational |
Details
|
Isophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insulin N |
Bangladesh |
Diabetes Mellitus |
Popular Pharmaceuticals |
2013-01-01 |
Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(30R)(Novo Nordisk ) |
|
Approved |
Novo Nordisk A/S |
诺和灵30R |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
1999-07-28 |
Diabetes Mellitus |
Details
|
Human insulin biosimilar (Square Pharmaceuticals) |
|
Approved |
Square Pharmaceuticals Ltd |
Ansulin |
Bangladesh |
Diabetes Mellitus |
Square Pharmaceuticals Ltd |
2013-01-01 |
Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech) |
|
Approved |
Shenzhen Kexing Biological Engineering Co Ltd |
苏泌啉恩 |
Mainland China |
Diabetes Mellitus |
Shenzhen Kexing Biological Engineering Co Ltd |
2003-02-24 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Getz Pharma) |
|
Approved |
Getz Pharma |
Basagine |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insulin glargine biosimilar (Biocon) |
MYL-1501D |
Approved |
Fujifilm Corp, Biocon Biopharmaceuticals, Mylan Nv |
Semglee, Basalog |
India |
Diabetes Mellitus |
null |
2009-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(40R)(Tonghua Dongbao) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Recombinant lispro insulin biosimilar (Gan & Lee) |
|
Approved |
Gan & Lee Pharmaceuticals |
Prandilin, 速秀霖 |
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2006-01-19 |
Diabetes Mellitus |
Details
|
Insulin lispro protamine(25R) (Lilly ) |
|
Approved |
Lilly Suzhou Pharmaceutical Co Ltd |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Recombinant human insulin (SciGen) |
|
Approved |
Generex Biotechnology Corp |
Recojet |
India |
Diabetes Mellitus |
null |
2004-12-01 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Shenzhen Kexing Biotech) |
|
Approved |
Shenzhen Kexing Biological Engineering Co Ltd |
苏泌啉, Su Bi Lin |
Mainland China |
Diabetes Mellitus |
Shenzhen Kexing Biological Engineering Co Ltd |
2002-06-10 |
Diabetes Mellitus |
Details
|
Imeglimin hydrochloride |
EMD-387008; PXL-008 |
Approved |
Merck KGaA, Darmstadt, Germany |
Twymeeg, ツイミーグ |
Japan |
Diabetes Mellitus, Type 2 |
Poxel Sa, Sumitomo Dainippon Pharma Co Ltd |
2021-06-23 |
Diabetes Mellitus, Type 2; Heart Diseases; Hepatic Insufficiency |
Details
|
Recombinant human insulin (Hefei Tianmai Biotechnology) |
|
Approved |
Hefei Tianmai Biotechnology Development Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Hefei Tianmai Biotechnology Development Co Ltd |
2018-04-28 |
Diabetes Mellitus |
Details
|
Rinsulin NPH (Geropharm) |
|
Approved |
Geropharm |
Rinsulin NPH |
Russian Federation |
Diabetes Mellitus |
Geropharm |
2012-10-01 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology) |
|
Approved |
Hefei Tianmai Biotechnology Development Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Hefei Tianmai Biotechnology Development Co Ltd |
2019-09-05 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Zhuhai United Laboratories) |
|
Approved |
Zhuhai United Laboratories Co Ltd |
联邦优倍灵, Ublin |
Mainland China |
Diabetes Mellitus |
Zhuhai United Laboratories Co Ltd |
2021-07-12 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Wanbang Biochemical) |
|
Approved |
Wanbang Biopharmaceuticals Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Wanbang Biopharmaceuticals Co Ltd |
2022-08-30 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(30R)(Lilly) |
|
Approved |
Eli Lilly And Company |
|
Mainland China |
Diabetes Mellitus |
Eli Lilly And Company |
|
Diabetes Mellitus |
Details
|
Insulin glulisine |
HMR-1964 |
Approved |
Sanofi |
艾倍得, Apidra |
United States |
Diabetes Mellitus |
Sanofi-Aventis U.S. Llc |
2004-04-16 |
Diabetes Mellitus, Type 1; Leukemia; Diabetes Mellitus, Type 2; Heart Failure; Myocardial Infarction; Down Syndrome; Hyperglycemia; Cardiovascular Diseases; Cognitive Dysfunction; Alzheimer Disease; Diabetes Mellitus; Respiratory Insufficiency |
Details
|
Insulin glargine biosimilar (Incepta Pharmaceuticals) |
|
Approved |
Incepta Pharmaceuticals Ltd |
|
Bangladesh |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Incepta Pharmaceuticals Ltd |
2012-08-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insulin lispro biosimilar (Wanbang Biopharma) |
|
Approved |
Wanbang Biopharmaceuticals Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Wanbang Biopharmaceuticals Co Ltd |
2022-01-25 |
Diabetes Mellitus |
Details
|
Insulin human |
HR-1799 |
Approved |
Sanofi Deutschland |
Insulin Human Winthrop |
EU |
Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis |
Sanofi-Aventis Deutschland Gmbh |
1997-02-21 |
Diabetic Coma; Diabetic Ketoacidosis; Glaucoma; Diabetes Mellitus |
Details
|
30/70 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖30R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2002-05-18 |
Diabetes Mellitus |
Details
|
Insulin Aspart 50(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2022-11-08 |
Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2021-10-19 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin Aspart 50 biosimilar (Jilin Huisheng Biological) |
|
Approved |
Jilin Huisheng Biopharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Jilin Huisheng Biopharmaceutical Co Ltd |
2023-12-26 |
Diabetes Mellitus |
Details
|
Recombinant insulin (Horizon Pharma/Ibatech) |
|
Approved |
Savient Pharmaceuticals Inc |
|
Poland |
Diabetes Mellitus, Type 1 |
null |
2002-07-01 |
Diabetes Mellitus, Type 1 |
Details
|
Recombinant human insulin (HEC Pharm) |
|
Approved |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
2020-06-05 |
Diabetes Mellitus |
Details
|
Insulin degludec |
NN-1250; Insulin-454 |
Approved |
Novo Nordisk A/S |
诺和达, Tresiba |
Japan |
Diabetes Mellitus, Type 2; Diabetes Mellitus; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2012-09-28 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Human insulin biosimilar (MJ Biopharm) |
|
Approved |
Mj Biopharm Pvt |
Biosulin |
India |
Diabetes Mellitus |
Mj Biopharm Pvt |
2005-12-01 |
Diabetes Mellitus |
Details
|
Insulin glargine |
U-300; Gla-100; Gla-300; Hoe-901; Hoe-71GT; HOE901-U300 |
Approved |
Sanofi |
来得时, Lantus, Toujeo, Lantus XR, Optisulin |
United States |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Sanofi-Aventis U.S. Llc |
2000-04-20 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Atherosclerosis; Hyperglycemia; Hypercholesterolemia; Hypertension; Coronary Disease; Cardiovascular Diseases; Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin (BIOTON) |
|
Approved |
Bioton Sa |
|
Mainland China |
Diabetes Mellitus |
Bioton Sa |
2013-03-29 |
Diabetes Mellitus |
Details
|
Insulin Aspart 30 (Yichang Hec Changjiang Pharmaceutical) |
|
Approved |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
2022-11-01 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin Glargine biosimilar (Liaoning Bo'Ao Bio-Pharmaceutical) |
|
Approved |
Liaoning Bo'Ao Bio-Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Liaoning Bo'Ao Bio-Pharmaceutical Co Ltd |
2023-12-05 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(30R)(Hec Pharm) |
|
Approved |
Hec Pharm Co Ltd |
诺和灵30R |
Mainland China |
Diabetes Mellitus |
Hec Pharm Co Ltd |
2023-09-19 |
Diabetes Mellitus |
Details
|
50/50 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖50R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2008-02-04 |
Diabetes Mellitus |
Details
|
Insulin biosimilars (Bioton) |
|
Approved |
Bioton Sa |
|
Mainland China |
Diabetes Mellitus |
Bioton Sa |
2013-01-01 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Incepta) |
|
Approved |
Incepta Pharmaceuticals Ltd |
Maxsulin |
Bangladesh |
Diabetes Mellitus |
Incepta Pharmaceuticals Ltd |
2012-01-01 |
Diabetes Mellitus |
Details
|
Insulin human (rDNA origin, Novo Nordisk) |
NN-729 |
Approved |
Novo Nordisk A/S |
Insulatard, Actraphane, Mixtard, Novolin R, 诺和灵R |
United States |
Diabetes Mellitus, Type 2 |
Novo Nordisk Inc |
1991-06-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Smoking Cessation; Hyperglycemia; Cognitive Dysfunction; Alzheimer Disease; Parkinson Disease; Alcoholism; Pulmonary Disease, Chronic Obstructive; Lymphoma; Diabetes Mellitus |
Details
|
Insulin aspart |
NN-1218; INA-X14; Insulin X14 |
Approved |
Novo Nordisk A/S |
Novolog, NovoRapid, NovoLog FlexPen, NovoMix, Fiasp, 诺和锐, NovoRapid/NovoLog |
EU |
Diabetes Mellitus |
Novo Nordisk A/S |
1999-09-07 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Atherosclerosis; Delirium; Hypercholesterolemia; Hypertension; Postoperative Cognitive Complications; Coronary Disease; Alzheimer Disease; Cognitive Dysfunction; Cardiovascular Diseases; Diabetes Mellitus |
Details
|
Recombinant insulin aspart biosimilar (Yichang Hec Changjiang Pharmaceutical) |
|
Approved |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
2022-10-11 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖, 甘舒霖R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
1998-01-01 |
Diabetes Mellitus |
Details
|
Recombinant Human Insulin (Wanbang Pharma) |
|
Approved |
Wanbang Biopharmaceuticals Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Wanbang Biopharmaceuticals Co Ltd |
2003-08-29 |
Diabetes Mellitus |
Details
|
Insulin human (rDNA) biosimilar (Baxter) |
|
Approved |
Baxter International Inc |
Inpremzia, Myxredlin |
United States |
Diabetes Mellitus |
Baxter Healthcare Corp |
2019-06-20 |
Diabetes Mellitus |
Details
|
Mixed Protamine Human Insulin(40R)(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖N |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
1999-01-01 |
Diabetes Mellitus |
Details
|
Insulin degludec/Liraglutide |
NN-9068 |
Approved |
Novo Nordisk A/S |
Xultophy, iDegLira |
EU |
Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2014-09-18 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Recombinant insulin glargine (Gan & Lee) |
GL-GLA |
Approved |
Gan & Lee Biotech |
长秀霖, Basalin |
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2005-05-10 |
Diabetes Mellitus, Type 1; Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(50R)(Novo Nordisk ) |
|
Approved |
Novo Nordisk A/S |
诺和灵50R |
Mainland China |
Diabetes Mellitus |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
2019-11-27 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Lilly/Boehringer Ingelheim) |
LY-2963016; LY2963016-U-100; LY2963016-U-200 |
Approved |
Boehringer Ingelheim Gmbh, Eli Lilly And Company |
Abasria, Basaglar, Abasaglar, Rezvoglar |
EU |
Diabetes Mellitus |
Eli Lilly Nederland BV |
2014-09-09 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia; Renal Insufficiency, Chronic; Diabetes Mellitus |
Details
|
Insulin Aspart 30(onghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2022-11-08 |
Diabetes Mellitus |
Details
|
Insulin human(Organon France) |
|
Approved |
Organon France |
|
EU |
Diabetes Mellitus |
Organon France |
1999-11-03 |
Diabetes Mellitus |
Details
|
Insulin biosimilar (Wockhardt) |
|
Approved |
Wockhardt Ltd |
Wosulin Pen Royale, Wosulin, Wosulin®-R, Wosulin Pen |
India |
Diabetes Mellitus, Type 1 |
Wockhardt Ltd |
2003-10-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus |
Details
|
Recombinant human insulin (United Laboratories International Holdings) |
|
Approved |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
优思灵, Uslin, 优思灵R |
Mainland China |
Diabetes Mellitus |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
2009-11-25 |
Diabetes Mellitus |
Details
|
Insulin lispro |
LY-900027; LY-275585; Lys-B28; Pro-B29; LYSPRO; LY-900014 |
Approved |
Eli Lilly And Company |
Humalog, 优泌乐, Eglucent, Liprolog, Lyumjev, Liumjev |
EU |
Diabetes Mellitus |
Eli Lilly Nederland BV |
1996-04-30 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Insulin Resistance; Diabetic Neuropathies; Diabetes Mellitus; Hyperlipidemias |
Details
|
Insulin aspart biosimilar(Jilin Huisheng Biological) |
|
Approved |
Jilin Huisheng Biopharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Jilin Huisheng Biopharmaceutical Co Ltd |
2023-12-26 |
Diabetes Mellitus |
Details
|
Isophane Insulin |
|
Approved |
Wanbang Biopharmaceuticals Co Ltd |
万苏林 |
Mainland China |
Diabetes Mellitus |
Wanbang Biopharmaceuticals Co Ltd |
1997-01-01 |
Diabetes Mellitus |
Details
|
Insulin biosimilar (Harvest Moon Pharmaceuticals) |
|
Approved |
Harvest Moon |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Insulin biosimilar (Julphar) |
|
Approved |
Julphar (Gulf Pharmaceutical Industries) |
Julphar Insulin R |
Tunisia |
Diabetes Mellitus |
Julphar (Gulf Pharmaceutical Industries) |
2013-10-01 |
Diabetes Mellitus |
Details
|
Insulin lispro biosimilar (Sanofi) |
SAR-342434 |
Approved |
Sanofi |
Admelog |
EU |
Diabetes Mellitus |
Sanofi Winthrop Industrie SA |
2017-07-18 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Recombinant human insulin (Biocon) |
|
Approved |
Biocon Ltd |
Insugen |
India |
Diabetes Mellitus |
Biocon Ltd |
2004-11-10 |
Diabetes Mellitus |
Details
|
Insulin detemir |
NN-304 |
Approved |
Novo Nordisk A/S |
诺和平, Levemir |
EU |
Diabetes Mellitus |
Novo Nordisk A/S |
2004-06-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Atherosclerosis; Hypercholesterolemia; Hypertension; Diabetes, Gestational; Coronary Disease; Alzheimer Disease; Cognitive Dysfunction; Cardiovascular Diseases; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
长舒霖 |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2019-12-06 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Biocon/Mylan) |
MYL-1601D |
Approved |
Biocon Ltd |
|
EU |
Diabetes Mellitus |
Biosimilar Collaborations Ireland Ltd |
2021-02-05 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Zhuhai United) |
|
Approved |
Zhuhai United Laboratories Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Zhuhai United Laboratories Co Ltd |
2016-12-23 |
Diabetes Mellitus |
Details
|
Insulin degludec/Insulin aspart |
NN-1045; NN-5401; NN-1250/Insulin aspart |
Approved |
Novo Nordisk A/S |
Ryzodeg, 诺和佳 |
Japan |
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2012-12-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(50R)(Zhuhai United Laboratories ) |
|
Approved |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
诺和灵50R |
Mainland China |
Diabetes Mellitus |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
2010-12-31 |
Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Sanofi) |
SAR-341402; SAR-Asp |
Approved |
Sanofi |
Truvelog |
EU |
Diabetes Mellitus |
Sanofi Winthrop Industrie SA |
2020-06-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Gan & Lee) |
GL-ASP |
Approved |
Gan & Lee Biotech |
Rapilin®30, Rapilin30, 锐秀霖30 |
Mainland China |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Gan & Lee Biotech |
2020-06-05 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin human (rDNA origin, Lilly) |
S-3300; LY-041001; U-500R |
Approved |
Eli Lilly And Company |
Humulin R Kwikpen, Humulin, Humulin R, 优泌淋R, Humulin R Pen |
United States |
Diabetes Mellitus, Type 2 |
Eli Lilly And Company |
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Brain Neoplasms; Alzheimer Disease; Cognitive Dysfunction; Intracranial Aneurysm; Diabetes Mellitus |
Details
|
Insulin Aspart 30 biosimilar (Jilin Huisheng Biological) |
|
Approved |
Jilin Huisheng Biopharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Jilin Huisheng Biopharmaceutical Co Ltd |
2023-12-26 |
Diabetes Mellitus |
Details
|
Ceritinib |
LDK-378; NVP-LDK378; NVP-LDK378-NX |
Approved |
Novartis Pharma Ag |
赞可达, Zykadia |
EU |
Carcinoma, Non-Small-Cell Lung |
Novartis Europharm Ltd |
2014-04-29 |
Colorectal Neoplasms; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms; Brain metastases; Esophageal adenocarcinoma; Granuloma, Plasma Cell; Lymphoma, Large-Cell, Anaplastic; Hematologic Neoplasms; Hepatic Insufficiency; Cholangiocarcinoma; Pancreatic Neoplasms; Thyroid Carcinoma, Anaplastic; Neoplasms; Glioblastoma; Stomach Neoplasms |
Details
|
Rosinsulin |
|
Approved |
Medsintez |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Hisun Pharma) |
|
Approved |
Zhejiang Hisun Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Zhejiang Hisun Pharmaceutical Co Ltd |
2021-09-13 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Wockhardt) |
|
Approved |
Wockhardt Bio Ag |
Glaritus, Glaritus Cart, Glaritus DispoPen |
India |
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Wockhardt Ltd |
2013-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (LG Life Sciences) |
|
Approved |
Lg Life Sciences Ltd |
Basugine |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Isophane Protamine Recombinant Human Insulin(Novo Nordisk) |
|
Approved |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
诺和灵N |
Mainland China |
Diabetes Mellitus |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
2016-06-16 |
Diabetes Mellitus |
Details
|
Insulin biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insul R |
Bangladesh |
Diabetes Mellitus |
Popular Pharmaceuticals |
2013-01-01 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar(Shandong New Time Pharmaceutical) |
|
Approved |
Lunan Pharmaceutical Group Co |
|
Mainland China |
Diabetes Mellitus |
Shandong New Time Pharmaceutical Co Ltd |
2022-05-10 |
Diabetes Mellitus |
Details
|
Isophane Insulin(Polish Society of Diabetology) |
|
Approved |
Polish Society of Diabetology |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Lixisenatide/Insulin glargine |
HOE-901/AVE-0010 |
Approved |
Sanofi |
Soliqua, iGlarLixi, Suliqua |
United States |
Diabetes Mellitus, Type 2 |
Sanofi-Aventis U.S. Llc |
2016-11-21 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insulin Aspart 50 |
|
Approved |
Novo Nordisk A/S |
诺和锐50 |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
2012-02-10 |
Diabetes Mellitus |
Details
|
Insulin lispro protamine biosimilar(25R) (Gan & Lee) |
|
Approved |
Gan & Lee Biotech |
Prandilin25, 速秀霖25 |
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2014-05-09 |
Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(30R)(Gan & Lee ) |
|
Approved |
Gan & Lee Pharmaceuticals |
|
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2021-05-19 |
Diabetes Mellitus |
Details
|
Insulin human (inhalation powder) |
SAR-439065 |
Approved |
Mannkind Corporation |
Technosphere Insulin System, Afrezza, Afresa |
United States |
Diabetes Mellitus, Type 2 |
Mannkind Corporation |
2014-06-27 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia; Asthma; Pulmonary Disease, Chronic Obstructive; Diabetes Mellitus |
Details
|
Insulin Aspart 30 |
|
Approved |
Novo Nordisk A/S |
诺和锐30 |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
2009-09-30 |
Diabetes Mellitus |
Details
|